Data Science Funding Opportunities

NOT-OD-21-011 Smart health and biomedical research in the age of artificial intelligence and advanced data science
This inter-agency program between NSF and NIH supports innovative high-risk/high-reward research with the promise of disruptive transformations in biomedical research, which can only be achieved through well-coordinated, convergent, and interdisciplinary approaches that draw on multiple areas of computer and information science, engineering, mathematical sciences, and biomedical, social, behavioral, and economic sciences. NSF Program Solicitation: NSF 21-530 November 10, 2022 PA-20-199 Framed Quantitative Research Development Fellowship (Unauthorized K25 Parent Independent Clinical Trial)
The K25 award provides support and “protected time” for a period of supervised study and research for productive professionals with a quantitative background (e.g. mathematics, statistics, economics, computer science, imaging science, computing, physics, chemistry) and engineering to integrate their expertise into relevant research at NIH. Standard dates PA-20-198 Framed Quantitative Research Development Fellowship (Parent K25 Independent Basic Experimental Studies with Humans Required)
The K25 award provides support and “protected time” for a period of supervised study and research for productive professionals with a quantitative background (e.g. mathematics, statistics, economics, computer science, imaging science, computing, physics, chemistry) and engineering to integrate their expertise into relevant research at NIH. Standard dates PA-20-197 Framed Quantitative Research Development Fellowship (parent K25 independent clinical trial required)
The K25 award provides support and “protected time” for a period of supervised study and research for productive professionals with a quantitative background (e.g. mathematics, statistics, economics, computer science, imaging science, computing, physics, chemistry) and engineering to integrate their expertise into relevant research at NIH. Standard dates BY-19-162 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Unauthorized Clinical Trial)
The purpose of this funding announcement is to encourage applications proposing analysis of the public-use dataset of the Adolescent Brain Cognitive Development (ABCD) study to increase knowledge about adolescent health and development. Standard dates PAR-20-100 Resources from the genomics community (unlicensed U24 clinical trial)
This funding opportunity supports genomic resources that are crucial for basic research, disease studies, model organism studies, and other biomedical research. Standard dates PAR-20-097 Biomedical Knowledge Base (U24 – Unauthorized Clinical Trials)
This funding opportunity announcement is designed to support biomedical knowledge bases. Biomedical knowledge bases should have the primary function of extracting, accumulating, organizing, annotating and linking growing masses of information related to basic data sets. September 26, 2022; January 25, 2023 PAR-20-089 Biomedical Data Repository (U24 – Unauthorized Clinical Trials)
This funding opportunity is designed to support biomedical data repositories. Biomedical data repositories should have the primary function of ingesting, archiving, storing, managing, distributing and making accessible data relating to one or more particular systems. September 26, 2022; January 25, 2023 RFA-HD-23-036 Centers of Excellence in Maternal Health Research Center for Innovation and Data Coordination/Resource Center (unlicensed U24 clinical trial)
This Funding Opportunity Announcement (FOA) invites applications for the Resource Center / Center for Innovation and Data Coordination for the Maternal Health Centers of Research Excellence initiative. December 6, 2022 RFA-OD-21-003 Secondary analyzes of existing tobacco use and health datasets (unlicensed R21 clinical trial)
This funding opportunity invites R21 applications proposing the innovative analysis of existing (publicly available) and nationally representative U.S. cross-sectional and longitudinal data, to investigate new scientific ideas and/or generate new models, systems, tools, methods, or technologies that have the potential to significantly impact biomedical or biobehavioral research in areas relevant to the Food and Drug Administration (FDA) – Center for Tobacco Products (CTP). March 8, 2023

Comments are closed.